The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

(2020) Michael J Rybak et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Relationship of vancomycin trough levels with acute kidney injury risk: an exposure–toxicity meta-analysis

(2020) Ioannis Bellos et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The risk of vancomycin toxicity in patients with liver impairment

(2020) Luigi Brunetti et al.   Annals of Clinical Microbiology and Antimicrobials

Reduced nephrotoxicity in vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15–20 μg/mL concentration

(2020) Kazutaka Oda et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Examining the relationship between vancomycin area under the concentration time curve and serum trough levels in adults with presumed or documented staphylococcal infections

(2019) Laura Clark et al.   THERAPEUTIC DRUG MONITORING

Conversion from Vancomycin Trough Concentration–Guided Dosing to Area Under the Curve–Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center

(2019) Lina Meng et al.   PHARMACOTHERAPY

Vancomycin Area under the Curve and Acute Kidney Injury: A Meta-analysis

(2019) Doaa M Aljefri et al.   CLINICAL INFECTIOUS DISEASES

Comparative performance of urinary biomarkers for vancomycin induced kidney injury according to timeline of injury

(2019) Gwendolyn M. Pais et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model

(2019) Sean N Avedissian et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Emperor’s New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)

(2019) Thomas P Lodise et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity

(2019) B.R. Dalton et al.   CLINICAL MICROBIOLOGY AND INFECTION

Evaluation of risk factors for vancomycin-induced nephrotoxicity

(2018) So Jin Park et al.   International Journal of Clinical Pharmacy

Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteremia

(2018) Bryan T. Mogle et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical outcomes after initial treatment of methicillin-resistant Staphylococcus aureus infections

(2018) Nobuaki Shime et al.   Infection and Drug Resistance

Is Trough Concentration of Vancomycin Predictive of the Area Under the Curve? A Clinical Study in Elderly Patients

(2017) Anis Bel Kamel et al.   THERAPEUTIC DRUG MONITORING

Vancomycin Trough and Acute Kidney Injury: A Large Retrospective, Cohort Study

(2016) Kassem Hammoud et al.   AMERICAN JOURNAL OF NEPHROLOGY

Clinical impact of methicillin-resistant staphylococcus aureus on bacterial pneumonia: cultivation and 16S ribosomal RNA gene analysis of bronchoalveolar lavage fluid

(2016) Toshinori Kawanami et al.   BMC INFECTIOUS DISEASES

Healthcare-associated pneumonia with positive respiratory methicillin-resistant S taphylococcus aureus culture: Predictors of the true pathogenicity

(2016) Yasunori Enomoto et al.   Geriatrics & Gerontology International

Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society

(2016) Zhi-Kang Ye et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience

(2016) Ryuichi Hirano et al.   Infection and Drug Resistance

Impact of area under the concentration–time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia

(2015) Kyoung-Ho Song et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Innovative approaches to optimizing the delivery of vancomycin in individual patients

(2014) Manjunath P. Pai et al.   ADVANCED DRUG DELIVERY REVIEWS

Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies

(2014) Steven L Barriere et al.   BMC INFECTIOUS DISEASES

Impact of Vancomycin or Linezolid Therapy on Development of Renal Dysfunction and Thrombocytopenia in Japanese Patients

(2014) Satoshi Fujii et al.   CHEMOTHERAPY

Impact of source of infection and vancomycin AUC0–24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus bacteraemia

(2014) N. Ghosh et al.   CLINICAL MICROBIOLOGY AND INFECTION

Predictors of the pathogenicity of methicillin-resistantStaphylococcus aureusnosocomial pneumonia

(2014) Kentaro Nagaoka et al.   RESPIROLOGY

Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection

(2013) Anthony M. Casapao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?

(2013) Michael N. Neely et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock

(2013) Sheryl Zelenitsky et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Area under the concentration–time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia

(2013) Younghee Jung et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

(2013) Kazuaki Matsumoto et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality

(2013) Eric J. Ley et al.   JOURNAL OF SURGICAL RESEARCH

The Relationship of Nephrotoxicity to Vancomycin Trough Serum Concentrations in a Veteran's Population: A Retrospective Analysis

(2012) Amy Horey et al.   ANNALS OF PHARMACOTHERAPY

Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter

(2012) S. J. van Hal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis

(2012) S. J. van Hal et al.   CLINICAL INFECTIOUS DISEASES

Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database

(2012) Ennie L. Cano et al.   CLINICAL THERAPEUTICS

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

(2011) R. Kullar et al.   CLINICAL INFECTIOUS DISEASES

Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremia

(2011) Evan C. Clemens et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans

(2011) Kavitha K. Prabaker et al.   Journal of Hospital Medicine

Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients

(2009) Thomas P. Lodise et al.   CLINICAL INFECTIOUS DISEASES

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections

(2009) Elizabeth D Hermsen et al.   Expert Opinion On Drug Safety

Current problems in the diagnosis and treatment of hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia

(2008) Masahiro Sakaguchi et al.   Journal of Anesthesia